OpenAI is rolling out the full, limited-release version of GPT-5.5-Cyber—a specialized AI model that outperforms its ...

The pop singer-songwriter’s debut was a critical success. Now, she’s taking the album on the road for her Staircase to Stardom tour, which she’s “entirely” involved in shaping: “Nothing is as fun as ...

GitHub has introduced the GitHub Copilot app, a desktop control centre for agent-native development that aims to keep ...

While the news coming out of WWDC 2026 is not as dramatic as last year's iOS 26 update, where the new Liquid Glass redesign caused a big stir, Apple’s presentation still made waves. During the WWDC ...

Back in 2023, Chris Lattner, creator of LLVM, and his team at Modular unveiled a new language called Mojo. Its syntax resembled Python, but it compiled to machine-native code and offered memory-safety ...

The Google I/O annual developer conference is around the corner—May 19—but in what is quickly becoming a tradition, Google announced new features for Android and Gemini a week early. The news came on ...

TAMPA, Fla.--(BUSINESS WIRE)--Concurrent Investment Advisors, LLC (“Concurrent”) has partnered with TAVO Wealth (“TAVO”), providing strategic transition guidance and support as the team launched its ...

Highlights of Python 3.15, now available in beta, include lazy imports, faster JITs, better error messages, and smarter profiling. The first full beta of Python 3.15 ...

I spoke with a doctor at Apple to learn more about the Apple Watch health features that you might not currently be using to support your wellness. Anna Gragert Senior Editor, Health and Home Anna ...

The Bahrain-based lender lets institutional clients convert fiat currency to US dollar-pegged stablecoins directly from their accounts. Singapore Gulf Bank (SGB) has introduced a service that lets ...

Anthropic is publicly releasing its most powerful large language model yet, Claude Opus 4.7, today — as it continues to keep an even more powerful successor, Mythos, restricted to a small number of ...

REDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a late-stage clinical oncology company developing targeted therapies for patients with RAS-addicted cancers, today ...